Connect your AI

Upstream Bio, Inc. UPB Payments to Acquire Short-Term Investments

Payments to Acquire Short-Term Investments at other companies

Minerals TechnologiesMTX

$1.3M-71.1%

PhotronicsPLAB

$69.22M+150%

Equitable HoldingsEQH

$8M-83.3%

DJT

Trump Media & Technology GroupDJT

$2.32M-63.3%

Playtika Holding Corp.PLTK

$0-100%

CorMedixCRMD

$0-100%

Other financials

Income statement

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s payments to acquire short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Upstream Bio, Inc.'s payments to acquire short-term investments?: Upstream Bio, Inc. (UPB) reported payments to acquire short-term investments of $14.42M in Q1 2026.
How has Upstream Bio, Inc.'s payments to acquire short-term investments changed year-over-year?: Upstream Bio, Inc.'s payments to acquire short-term investments decreased by 94.6% year-over-year, from $266.06M to $14.42M.